Research member at the Institute, John Stagg, and other researchers have published a major scientific paper in the prestigious journal Annals of Oncology. Entitled Leveraging Big Data of Immune Checkpoint Blockade Response Identifies Novel Potential Targets, the paper describes a new signature for predicting clinical responses to immunotherapy. To view the article, click here.